Hainan Boao Le City Pioneer Zone and China Leading Medical Health Industry Group Fosun Pharmaceutical Cooperation Signing contract

On June 27, Hainan Boao Lele City International Medical Tourism District Administration (hereinafter referred to as the "Lecheng Administration") and Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (hereinafter referred to as "Fosun Pharmaceutical") signed a cooperation agreement.

The two parties will carry out cooperation in the transformation and application of innovative drugs, diagnostic technology and products based on the real world data of LEG City, the first trial and first trial, the introduction of clinical urgent need of overseas medicine, regional cooperation in medical institutions, and strengthening discipline talent training to further promote the world. The introduction and implementation of innovative treatment plan helps the convenience and convenience of high -quality medical and health services to meet the clinical needs of more Chinese patients.

Jia Ning, Director of Ledong Management Bureau, Li Yunda, deputy director of Hainan Provincial Drug Administration, Fu Zhuzhu, deputy director of the Locheng Management Bureau, Wang Yanfang, director of the Health Industry and Foreign Cooperation Bureau of the Health and Health Commission of the Hainan Provincial Health and Health Commission, Chen Linmin Chen Qiyu, executive director of Fosun International and co -CEO, Wang Kexin, vice president of Fosun International and co -chairman of Fosun Pharmaceutical, attended the signing ceremony.

Fu Zhu represented the Lecheng Administration Bureau and Wang Kexin signed a contract on behalf of Fosun Pharmaceutical. Jia Ning, Li Yunda, Wang Yanfang, Chen Linmin, and Chen Qiyu witnessed the contract.

As the only "Medical Zone" in the construction of Hainan Free Trade Port, LECO has a unique innovation policy and location advantage. Fosun Pharmaceuticals takes innovative research and development as its core driving factor, and has mature R & D, clinical trials, production, and sales of the entire industry chain Capacity and successful experience in the introduction of many global leading products. The signing of this cooperation agreement means that the two parties will jointly explore the reform and innovation of pharmaceutical policy in the context of the construction of a free trade port with Chinese characteristics, and try first, and further extend the industrial chain of both parties, enrich the industry format, and promote the international medical tourism tourism tourism tourism tourism. And high -standard and high -quality development of high -end medical services.

Jia Ning, the director of the Lecheng Pioneering District Management Bureau, said:

The signing and cooperation is another important measure to implement the spirit of Secretary Shen Xiaoming's speech during the investigation of the Speaking of Shen Xiaoming during the investigation of the Lecheng Pioneer District. The signing of this cooperation agreement will fully play the advantages of the Lecheng Pioneer District Policy, Natural Resources, and Industrial Basic, gather the advantages, technology, and research and development of Fosun Pharmaceutical Company to promote complementary advantages, deepening cooperation, and common development of both parties. In the future, the two parties will rely on their respective resources to accelerate the application of the transformation of innovative drugs, medical devices, diagnostic technology and products, and promote the gathering of high -quality medical resources and medical science and technology innovation resources. The Lecheng Administration will provide full efforts to provide high -quality and efficient services, promote the implementation of the cooperation agreement, and help Hainan's high -quality development of the medical and health industry and the biomedical industry in Hainan.

Chen Qiyu, Executive Director and Co -CEO of Fosun International, said:

Lecheng has special location advantages and policy advantages, superimposed the innovative policies and expert resources of the real world research of Lecheng, so that Locheng has a larger industrial introduction advantage. As a pioneer in the internationalization of the field of great health, Fosun Pharmaceuticals, this time, cooperates with Locheng, is also based on the active implementation of the supporting policies of Lecheng in all aspects of innovative drugs and the development of industrial clusters. It is hoped that through the cooperation between the two parties, Fosun Pharmaceuticals can integrate into the "hot land" of the medical tourism reform and opening up of Lecheng, integrate into the development of Hainan, share the "Local City Plan" and "Hainan Wisdom", and become a world -class international medical treatment for Lecheng. Tourism destinations and medical technology innovation platforms have a "Fosun's power" to meet the needs of more patients and help the construction of high -quality and high standards for Hainan Free Trade Port.

It is reported that Fosun Pharmaceutical has a number of medical institutions in many key areas such as the Greater Bay Area and the Yangtze River Delta, and has high -quality discipline expert resources and rich operating experience. The Ledong Xianxing District has brand effects, medical and health industry clusters, good good Ecological environment and rich tourism resources around. The two parties will jointly promote the sharing of high -quality medical resources through this cooperation, and provide more patients with physical examination and health management, traditional Chinese medicine health care services such as medical examinations and health management. In the future, the two parties will continue to explore the opportunity of broad cooperation opportunities in medical, teaching, research, and production to jointly promote the innovation and development of my country's large health industry. Xie Dazhi, Lifetime Dean of Foshan Foshan Zencheng Hospital, Hu Hang, senior vice president of Fosun Pharmaceutical, CEO of Foshan Health, Foshan Foshan Zencheng Hospital, senior vice president of Fosun Medicine, Chairman of the Medical Diagnosis Division, Bao Qin Gui, Liu Zhongsen, Assistant to Fosun International President, and Chief Executive Representative of Hainan participated in the signing event.

About Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharmaceutical", stock code: 600196.SH, 02196.HK) was established in 1994. It is a global pharmaceutical health industry group rooted in China and innovation -driven. The operations of operation include pharmaceutical, medical device and medical diagnosis, medical and health services, and cover the medical business field through the participation of Chinese medicine holding.

Fosun Pharmaceutical is centered on patients and clinical needs. It has enriched innovative product pipelines through independent research and development, cooperative development, license introduction, and deep incubation, and enrich the pipeline of innovation. Focusing on tumor and immunomotive regulation, metabolism and digestive systems, and central nervous system, Fosun Pharmaceuticals has been established and formed and formed by small molecular innovation drugs, antibody drugs, cell therapy technology platforms, and actively explore RNA, tumor virus, gene therapy , A targeted protein degradation and other cutting -edge technologies to improve innovation capabilities.

- END -